Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Tail - thickness
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total T cells - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Coat - hair distribution - back
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Eye Morphology / Left vitreous humour thickness
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.474
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Cytotoxic T cell function / Incubation time
|
HET
|
2f:1m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Hematology / Mean cell hemoglobin concentration
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0378
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
DSS Histology / Comment
|
HOM
|
f:1m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
DSS Histology / Comment
|
HET
|
f:m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / CD5+ gd T cells - cell count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Indirect Calorimetry / Body weight before experiment
|
HET
|
f:8m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Acoustic Startle and Pre-pulse Inhibition (PPI) / Response amplitude - PP2
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total myeloid cells - % of CD45+
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total B cells - % of CD45+
|
HET
|
2f:1m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F3 average volume of LC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Auditory Brain Stem Response / 6kHz-evoked ABR Threshold
|
HET
|
8f:8m
|
Reference Range Plus Test framework; quantile = 0.95 (Tails probability = 0.025)
|
0.0261
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector gd T cells - % of gd T cells
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F3 LC count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Thyroid
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Thyroid
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Thyroid
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Thyroid
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Plasmacytoid DC - % of DC
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting Treg cells - cell count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector Treg cells - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Eye Morphology / Lens Opacity
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Skin texture - back paws
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Conventional DC (cDC) - % of CD45+
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Pro-B cells (Hardy fraction C) - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Open Field / Periphery distance travelled
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.204
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Follicular B cells - % of B2 cells
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Marginal zone precursor B cells - % of CD45+
|
HET
|
2f:1m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Eosinophils - cell count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
X-ray / Zygomatic bone
|
HET
|
5f:5m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / T cells - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Calcium
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.412
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / 3i B cell panel
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Immunophenotyping / B1B Cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Echo / HR
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0629
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / B cell panel singlets cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
X-ray / Shape of ribs
|
HET
|
5f:5m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / B cell panel singlets cell count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Skin color - ear
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Electrocardiogram (ECG) / Number of signals
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total CD4- NKT cells - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / CD4+ T helper cells - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ alpha beta T cell percentage
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ alpha beta T cell percentage
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total ab T cells - cell count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Pro-B cells (Hardy fractions B and C) - % of CD45
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Myeloid cells - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Auditory Brain Stem Response / 30kHz-evoked ABR Threshold
|
HET
|
8f:8m
|
Reference Range Plus Test framework; quantile = 0.95 (Tails probability = 0.025)
|
0.0261
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / B2 t1 + t2 cells - % of B2 cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total CD8+ T cells - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Germinal centre B cells - % of B2 cells
|
HET
|
2f:1m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F3 average volume of CD45+ vg5- MHC II- cells
|
HET
|
f:1m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Viability Primary Screen / Viability Outcome
|
HOM
|
f:m
|
Supplied as data
|
0.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Viability Primary Screen / Viability Outcome
|
HOM
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Genitalia - morphology
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ CD4- NKT cells - % of CD4- NKT cells
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / B cell panel lymphocyte gate cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Lymph node
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Lymph node
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Lymph node
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Lymph node
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total gd T cells - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Hematology / Lymphocyte cell count
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0175
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total CD5+ T cells - IMPC panel cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Eye Morphology / Corneal vascularization
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Eye Morphology / Retinal Blood Vessels Pattern
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
0.000708
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F1 count of vg5+ DETC contacting LC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Triglycerides
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.757
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / B2 t1 + t2 cells - % of CD45+
|
HET
|
2f:1m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Hematology / Platelet count
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.401
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Acoustic Startle and Pre-pulse Inhibition (PPI) / Response amplitude - PP1
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Cytotoxic T cell function / Days post activation
|
HET
|
2f:1m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector Treg cells - cell count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Follicular B cells - % of B2 cells
|
HET
|
2f:1m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Ly6C+ CD5+ T cells - % of CD5+ T cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Thymus
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Thymus
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Thymus
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Thymus
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total DC - % of myeloid cells
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Hindlimbs - position
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD8+ CD44+ CD62L- alpha beta effector T cell percentage
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD8+ CD44+ CD62L- alpha beta effector T cell percentage
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Plasmacytoid DC - % of CD45+
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Cytotoxic T cell function / Comment
|
HET
|
f:m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Macrophages - % of myeloid cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Conventional DC (cDC) - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Tail - morphology
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Coat - color pattern - abdomen
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / B1a cells - % of B cells
|
HET
|
2f:1m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector CD4- NKT cells - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / CD5+ gd T cells - % of gd T cells
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F1 ratio of vg5+ DETC/LC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Immunophenotyping / cDCs
|
HET
|
3f:3m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Grip Strength / Forelimb and hindlimb grip strength measurement mean
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.974
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting CD4+ NKT cells - % of CD45+
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD8+ alpha beta T cell percentage
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD8+ alpha beta T cell percentage
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting Treg cells - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Myeloid panel lymphocyte gate cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Eye Morphology / Lens
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector CD4+ T helper cells - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / CD11b-high cDC - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total DC - cell count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / KLRG1+ mature NK cell percentage
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / KLRG1+ mature NK cell percentage
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Challenge Whole Body Plethysmography / Enhanced pause (Penh)
|
HET
|
432f:402m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Immunophenotyping / B2B Cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F1 average roundness of vg5+ DETC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Granulocytes - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / 3i Myeloid panel
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Skin color - snout
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ CD8+ T cells - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total T cells - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Skin
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Skin
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Skin
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Skin
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F2 ratio of CD45+ vg5- MHC II- cells/vg5+ DETC
|
HET
|
f:1m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Comments
|
HET
|
f:m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Immunophenotyping / Spleen weight
|
HET
|
3f:3m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / HDL-cholesterol
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.592
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Eye Morphology / Persistence of hyaloid vascular system
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
0.881
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / B2 t3 + f1+ f2 + gc cells - % of CD45+
|
HET
|
2f:1m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Eosinophils - % of myeloid cells
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F3 CD45+ vg5- MHC II- cell count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
X-ray / Processes on vertebrae
|
HET
|
5f:5m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / B2 t3 + f1 + f2 + gc cells - % of B2 cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Eye Morphology / Right vitreous humor thickness
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.507
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Granulocytes - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
X-ray / Maxilla/Pre-maxilla
|
HET
|
5f:5m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total CD4+ T cells - cell count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F2 average volume of CD45+ vg5- MHC II- cells
|
HET
|
f:1m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Hematology / Lymphocyte differential count
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0629
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Mature NK cells - % of NK cellls
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Mouth morphology
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / T cell panel singlets cell count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Transitional 2 B cells - % of B2 cells
|
HET
|
2f:1m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting NK cells - % of NK cells
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Head bobbing
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / B2 marginal zone + precursor cells - % of CD45+
|
HET
|
2f:1m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Skin texture - ear
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Body Composition (DEXA lean/fat) / Body weight
|
HET
|
8f:6m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / B2 marginal zone + precursor cells - % of B2 cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total DC - % of CD45+
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting CD4- NKT cells - % of CD4- NKT cells
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting Treg cells - % of Treg
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Transitional 1 B cells - % of B2 cells
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F2 CD45+ vg5- MHC II- cell count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Genitalia - size
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Open Field / Periphery permanence time
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.844
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Plasmacytoid DC - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F3 average branch length of LC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Echo / LVAWd
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.827
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total ab T cells - % of total T cells
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average branch length of LC
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Hindlimbs - shape
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Grip Strength / Forelimb grip strength measurement mean
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.664
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Immunophenotyping / Percentage of live gated events in Panel B
|
HET
|
3f:3m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Granulocytes + monocytes - % of myeloid cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Rotarod / Latency to fall
|
HET
|
24f:24m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Marginal zone B cells - % of CD45+
|
HET
|
2f:1m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Acoustic Startle and Pre-pulse Inhibition (PPI) / Response amplitude - BN
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Monocytes - cell count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
DSS Histology / Pre-Day 10 Death
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
DSS Histology / Pre-Day 10 Death
|
HOM
|
4f:4m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Gall bladder
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Gall bladder
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Gall bladder
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Gall bladder
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F3 average volume of vg5+ DETC contacting LC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Eye Morphology / Cornea
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
0.101
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Germinal centre B cells - % of B2 cells
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting CD4+ T helper cells - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Auditory Brain Stem Response / 12kHz-evoked ABR Threshold
|
HET
|
8f:8m
|
Reference Range Plus Test framework; quantile = 0.95 (Tails probability = 0.025)
|
0.0840
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / CD4+ T helper cells - cell count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Fear Conditioning / % Freezing duration pre-cue-2
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.865
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting CD8+ T cells - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Immature B cells (Hardy fraction E) - % of B220+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Eosinophil percentage
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Eosinophil percentage
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Rotarod / Body weight
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector gd T cells - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Granulocytes + monocytes - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Memory B cells - cell count
|
HET
|
2f:1m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / LIH (Hemolysis Severity - available on AU analysers)
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ Treg cells - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Transitional 2 B cells - % of CD45+
|
HET
|
2f:1m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Skin texture - tail
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / IMPC panel lymphocyte gate cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Eye Morphology / Iris Pigmentation
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Immunophenotyping / MZB
|
HET
|
3f:3m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ KLRG1+ alpha beta T cell percentage
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ KLRG1+ alpha beta T cell percentage
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Eye Morphology / Lacrimation
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Tissue dissociation method
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / CD11b-high cDC - % of cDC
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / BM panel singlets cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Cytotoxic T cell function / 0.3125:1 stdev
|
HET
|
2f:1m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Immunophenotyping / NKT Cells (panel B)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Hematology / Neutrophil cell count
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.515
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector gd T cells - cell count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / CD103+ CD11b-low cDC - cell count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
X-ray / Humerus
|
HET
|
5f:5m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector CD4+ NKT cells - % of CD4+ NKT cells
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F1 average branch length of vg5+ DETC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Large intestine
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Large intestine
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Large intestine
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Large intestine
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Limb grasp
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
0.0700
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F3 ratio of CD45+ vg5- MHC II- cells/vg5+ DETC
|
HET
|
f:1m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Monocytes - % of myeloid cells
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Total B cells - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / B2 t1 + t2 cells - % of lymphocytes
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Genitalia - presence
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Open Field / Periphery resting time
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.390
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Eosinophils - % of CD45+
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Memory B cells - % of B2 cells
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F1 CD45+ vg5- MHC II- cell count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector Treg cells - % of Treg
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F2 average branch length of LC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / BM panel live cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total DC - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Tail - length
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Stomach
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Stomach
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Stomach
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Stomach
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Indirect Calorimetry / Body weight after experiment
|
HET
|
f:8m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ NK cells - % of NK cells
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Memory B cells - % of CD45+
|
HET
|
2f:1m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Open Field / Distance travelled
|
HET
|
32f:32m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Hindlimbs - size
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Skin texture - front paws
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Rotarod / Latency to fall mean
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.453
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Body Composition (DEXA lean/fat) / Bone Area
|
HET
|
8f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.331
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F1 tissue volume
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Electrocardiogram (ECG) / QT
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.446
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total CD4+ T cells - % of ab T cells
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Echo / LVIDs
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.150
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Transitional 2 B cells - % of B2 cells
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F2 average volume of vg5+ DETC contacting LC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Heart
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Heart
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Heart
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Heart
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Granulocytes - cell count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Mature B cells (Hardy fraction F) - % of B220+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Transitional 1 B cells - % of B2 cells
|
HET
|
2f:1m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ Treg cells - cell count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F1 average volume of vg5+ DETC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F2 average branch length of vg5+ DETC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Skin color - front paws
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Trachea
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Trachea
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Trachea
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Trachea
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total CD8+ T cells - cell count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Mature B cells (Hardy fraction F) - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ CD4+ T helper cells - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD8+ KLRG1+ alpha beta T cell percentage
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD8+ KLRG1+ alpha beta T cell percentage
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Glucose
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.133
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector CD8+ T cells - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Rotarod / Passive rotation
|
HET
|
24f:24m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Eye Morphology / Corneal ulcer
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
1.73×10-05
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Pre-pro B cells (Hardy fraction A) - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
X-ray / Skull shape
|
HET
|
5f:5m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector CD4+ T helper cells - cell count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Transitional 1 B cells - % of CD45+
|
HET
|
2f:1m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Echo / Fractional Shortening
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0963
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F1 average volume of vg5+ DETC contacting LC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Indirect Calorimetry / Oxygen consumption
|
HET
|
f:128m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Small intestine
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Small intestine
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Small intestine
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Small intestine
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Ly6C+ NKT cells - IMPC panel cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Tail - presence
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total CD8+ T cells - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Eye Morphology / Pupil Light Response
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Fear Conditioning / % Freezing duration pre-cue-1
|
HET
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.224
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Eye Morphology / Corneal opacity
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
0.751
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / CD11b-low cDC - % of cDC
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Cytotoxic T cell function / 0.625:1 stdev
|
HET
|
2f:1m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Macrophages - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Immunophenotyping / B Cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / CD5+ gd T cells - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Collagenase digestion
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total CD4+ NKT cells - % of NKT cells
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / B cell panel CD45+ live cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average branch length of vg5+ DETC contacting LC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.243
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Echo / LVPWd
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.815
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Forelimb nail - shape
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Comment
|
HET
|
f:m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Electrocardiogram (ECG) / RR
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.253
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Granulocytes - % of myeloid cells
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Eosinophils - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ NK cells - % of NK cells
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Trunk curl
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Plasma cells - % of CD45+
|
HET
|
2f:1m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Naive CD8+ T cells - % of CD8+
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
X-ray / Number of thoracic vertebrae
|
HET
|
5f:5m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F1 ratio of contacting/not contacting vg5+ DETC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Marginal zone precursor B cells - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / CD11b-low cDC - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / CD11b-low cDC - cell count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Fear Conditioning / % Context freezing total
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.182
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Open Field / Percentage center time
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.844
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / NKT cell percentage
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / NKT cell percentage
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Granulocytes + monocytes - cell count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Vibrissae - presence
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
0.619
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting gd T cells - % of gd T cells
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Lower teeth appearance
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Open Field / Number of Rears
|
HET
|
24f:28m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / CD4+ T helper cells - % of CD4+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total B2 cells - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Plasma cells - % of B2 cells
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total B2 cells - cell count
|
HET
|
2f:1m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Cytotoxic T cell function / Killing assay kit
|
HET
|
2f:1m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ gd T cells - cell count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Immunophenotyping / NKT cells (panel A)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Cytotoxic T cell function / 1.25:1 stdev
|
HET
|
2f:1m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting Treg cells - % of CD45+
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Marginal zone B cells - cell count
|
HET
|
2f:1m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ CD4- NKT cells - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Epididymis
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Epididymis
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Epididymis
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Epididymis
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Esophagus
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Esophagus
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Esophagus
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Esophagus
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Memory B cells - % of B2 cells
|
HET
|
2f:1m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Coat - hair texture / appearance - head
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F2 average volume of vg5+ DETC not contacting LC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Acoustic Startle and Pre-pulse Inhibition (PPI) / Response amplitude - PP1_S
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ CD44+ CD62L- alpha beta effector T cell number
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ CD44+ CD62L- alpha beta effector T cell number
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total Treg cells - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / CD103+ CD11b-low cDC - % of CD11b-low cDC
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Body Composition (DEXA lean/fat) / Fat mass
|
HET
|
8f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.718
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Pro-B cells (Hardy fraction C) - % of B220+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / KLRG1+ mature NK cell number
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / KLRG1+ mature NK cell number
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector CD8+ T cells - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ CD4- NKT cells - % of CD45+
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / B1a cells - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total myeloid cells - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Immunophenotyping / RP Macrophage (F4/80+)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Transitional 1 B cells - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Upper teeth appearance
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector NK cells - % of NK cells
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total CD4- NKT cells - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / B cell percentage
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / B cell percentage
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Eye Morphology / Right total retinal thickness
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.302
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Marginal zone B cells - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Auditory Brain Stem Response / Body weight
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Activity (body position)
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Liver
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Liver
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Liver
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Liver
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Ratio of contacting/not contacting vg5+ DETC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Myeloid panel CD45+ live cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Macrophages - cell count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Late germinal centre B cells - % of GC cells
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting CD4- NKT cells - % of CD45+
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F2 average no of branches on LC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average branch length of vg5+ DETC not contacting LC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Ratio of CD45+ vg5- MHC II- cells/vg5+ DETC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / B2 t3 + f1+ f2 + gc cells - IMPC panel cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Immunophenotyping / T Cells (panel B)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector gd T cells - % of gd T cells
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
X-ray / Number of cervical vertebrae
|
HET
|
5f:5m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Eye Morphology / Eyelid closure
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / B1a cells - cell count
|
HET
|
2f:1m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / CD103+ CD11b-low cDC - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Echo / LVIDd
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.173
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Gamma delta T cell percentage
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Gamma delta T cell percentage
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Hindlimb nail - length
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.399
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector Treg cells - % of CD45+
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F3 average roundness of vg5+ DETC not contacting LC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Late germinal centre B cells - % of CD45+
|
HET
|
2f:1m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting NK cells - % of NK cells
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / B cell panel live cell count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F2 average roundness of vg5+ DETC not contacting LC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting CD4- NKT cells - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
X-ray / Syndactylism
|
HET
|
5f:5m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Open Field / Whole arena resting time
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.172
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Plasma cells - % of B2 cells
|
HET
|
2f:1m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Teeth presence
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F1 average volume of vg5+ DETC not contacting LC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Cytotoxic T cell function / 2.5:1 stdev
|
HET
|
2f:1m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Ly6C+ NKT cells - % of lymphocytes
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / CD103+ CD11b-low cDC - % of CD45+
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total CD4+ T cells - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Eye Morphology / Narrow eye opening
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Immunophenotyping / NK cells (panel A)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / CD11b-low cDC - % of cDC
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Pre-B cells (Hardy fraction D) - % of B220+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting CD4+ NKT cells - % of CD4+ NKT cells
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Memory B cells - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Prostate
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Prostate
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Prostate
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Prostate
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F3 average no of branches on LC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Coat - hair texture / appearance - back
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total B cells - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average volume of vg5+ DETC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Lung
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Lung
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Lung
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Lung
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ KLRG1+ alpha beta T cell number
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ KLRG1+ alpha beta T cell number
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / IgD+ mature B cell percentage
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / IgD+ mature B cell percentage
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Acoustic Startle and Pre-pulse Inhibition (PPI) / Response amplitude - S
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.187
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting gd T cells - cell count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total NK cells - % of CD45+
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Monocytes - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Eye Morphology / Right anterior chamber depth
|
HET
|
6f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.518
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting CD8+ T cells - % of CD8+
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total myeloid cells - cell count
|
HET
|
2f:1m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Fear Conditioning / % Freezing duration context-2
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.118
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F3 ratio of contacting/not contacting vg5+ DETC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Hematology / Sample clotted
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total Treg cells - cell count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total gd T cells - % of total T cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Naive CD8+ T cells - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Plasma cells - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Snout size
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Open Field / Distance travelled - total
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0838
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Eye Morphology / Synechia
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Total cholesterol
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.357
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Cholesterol ratio
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.276
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Monocyte percentage
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Monocyte percentage
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HET
|
3f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Electrocardiogram (ECG) / HR
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.678
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / T cell panel live cell count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
X-ray / Pelvis
|
HET
|
5f:5m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Early germinal centre B cells - % of CD45+
|
HET
|
2f:1m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / B2 t1 + t2 cells - IMPC panel cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total CD4- NKT cells - cell count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F1 average no of branches on LC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Urinary bladder
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Urinary bladder
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Urinary bladder
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Eye Morphology / Eyelid morphology
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / T cell panel singlets cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Challenge Whole Body Plethysmography / Tidal volume (TVb)
|
HET
|
432f:402m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Type of gd T cell
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / CD11b-low cDC - % of CD45+
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total ab T cells - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Grip Strength / Forelimb grip strength measurement
|
HET
|
24f:24m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Open Field / Whole arena permanence
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Hindpaw - size
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total ab T cells - % of total T cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / CD11b-high cDC - % of cDC
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total NKT cells - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Immunophenotyping / cDCs CD11b Type
|
HET
|
3f:3m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F1 average roundness of vg5+ DETC not contacting LC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Myeloid cells - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Skeletal muscle
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Skeletal muscle
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Skeletal muscle
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Skeletal muscle
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Cytotoxic T cell function / 5:1 stdev
|
HET
|
2f:1m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Acoustic Startle and Pre-pulse Inhibition (PPI) / % Pre-pulse inhibition - PPI1
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.376
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Acoustic Startle and Pre-pulse Inhibition (PPI) / Response amplitude - PP4
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting CD4- NKT cells - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Early germinal centre B cells - % of GC cells
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total CD8+ T cells - % of CD45+
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ CD4+ NKT cells - % of CD4+ NKT cells
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Eye Morphology / Right corneal thickness
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.813
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector CD4+ NKT cells - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Ly6C+ immature NK cells - % of immature NK cells
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F1 average volume of LC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average branch length of vg5+ DETC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Late germinal centre B cells - % of B2 cells
|
HET
|
2f:1m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Granulocytes - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Skin color - whole body
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector CD4+ NKT cells - % of CD45+
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Immunophenotyping / Percentage of live gated events in Panel A
|
HET
|
3f:3m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
X-ray / Number of digits
|
HET
|
5f:5m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Coat - hair distribution - abdomen
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Pro-B cells (Hardy fractions B and C) - % of B220+
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Comment
|
HET
|
f:m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Total T cell percentage
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Total T cell percentage
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ CD8+ T cells - % of CD8+
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Conventional DC (cDC) - % of DC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
DSS Histology / Average histology score
|
HOM
|
4f:4m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
DSS Histology / Average histology score
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Ly6Chigh monocyte percentage
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Ly6Chigh monocyte percentage
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F2 ratio of contacting/not contacting vg5+ DETC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F3 average no of branches on vg5+ DETC not contacting LC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Hindlimb nail - shape
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Coat - hair distribution - head
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.216
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Eye Morphology / Eye Hemorrhage or Blood Presence
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Open Field / Number of rears - total
|
HET
|
6f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.832
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Fear Conditioning / % Freezing duration context-3
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.117
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Immature NK cells - % of NK cells
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Cytotoxic T cell function / 10:1 stdev
|
HET
|
2f:1m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Body Weight / Body weight
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Eye Morphology / Fusion between cornea and lens
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Fear Conditioning / % Cue freezing total
|
HET
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.00854
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Heart Weight / Heart weight normalised against tibia length
|
HET
|
5f:5m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Forepaw - size
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HET
|
3f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.493
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Hematology / Large Unstained Cell (LUC) differential count
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.498
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
X-ray / Fusion of ribs
|
HET
|
5f:5m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / T cells - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Conventional DC (cDC) - % of DC
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting CD8+ T cells - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / B2 marginal zone + precursor cells - IMPC panel cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ gd T cells - % of gd T cells
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Testes
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Testes
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Testes
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Testes
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Plasma cells - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F2 count of vg5+ DETC contacting LC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Germinal centre B cells - % of CD45+
|
HET
|
2f:1m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / CD11b-high cDC - % of CD45+
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD8+ CD44+ CD62L- alpha beta effector T cell number
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD8+ CD44+ CD62L- alpha beta effector T cell number
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
X-ray / Joints
|
HET
|
5f:5m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Grip Strength / Forelimb and hindlimb grip strength measurement
|
HET
|
24f:24m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ Treg cells - % of CD45+
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Myeloid panel singlets cell count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total NKT cells - cell count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Immunophenotyping / pDCs
|
HET
|
3f:3m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Ears
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total CD4+ NKT cells - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F3 average volume of vg5+ DETC not contacting LC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total CD4+ NKT cells - % of CD45+
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Granulocytes + monocytes - % of CD45+
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Alpha beta T cell percentage
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Alpha beta T cell percentage
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average no of branches on LC
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Acoustic Startle and Pre-pulse Inhibition (PPI) / Response amplitude - PP3
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector CD4- NKT cells - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
DSS Histology / Total section 2 score
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
DSS Histology / Total section 2 score
|
HOM
|
4f:4m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Open Field / Whole arena average speed
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.145
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Pro-B cells (Hardy fraction B) - % of B220+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Ly6C+ CD5+ T cells - IMPC panel cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Early germinal centre B cells - % of B2 cells
|
HET
|
2f:1m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total T cells - % of CD45+
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total Treg cells - % of CD4+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Challenge Whole Body Plethysmography / Frequency of breathing (f)
|
HET
|
432f:402m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / B2 t3 + f1+ f2 + gc cells - cell count
|
HET
|
2f:1m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector gd cells - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F2 average volume of LC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Eye Morphology / Bulging eye
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total CD4+ NKT cells - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Mature NK cells - IMPC panel cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / B cell number
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / B cell number
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total B2 cells - IMPC panel cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / NKT cell number
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / NKT cell number
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Pre-pro B cells (Hardy fraction A) - % of B220+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting CD4- NKT cells - cell count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ CD4+ NKT cells - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ Treg cells - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Eye Morphology / Iris/Pupil
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F2 average no of branches on vg5+ DETC not contacting LC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total gd T cells - cell count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Fear Conditioning / % Pre-cue freezing total
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.883
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Heart Weight / Heart weight normalised against body weight
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Eye Morphology / Corneal deposits
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Indirect Calorimetry / Total food intake
|
HET
|
f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.576
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
X-ray / Fibula
|
HET
|
5f:5m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
X-ray / Shape of vertebrae
|
HET
|
5f:5m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Naive CD8+ T cells - % of CD8+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Fear Conditioning / % Freezing duration cue-2
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Body Composition (DEXA lean/fat) / Body length
|
HET
|
8f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.0729
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ gd T cells - % of CD45+
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Cytotoxic T cell function / % lysis
|
HET
|
12f:6m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Transitional 2 B cells - cell count
|
HET
|
2f:1m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Ly6C+ mature NK cells - % of mature NK cells
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F1 average roundness of vg5+ DETC contacting LC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Forelimbs - shape
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Ly6Clow monocyte percentage
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Ly6Clow monocyte percentage
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector CD4+ T helper cells - % of CD45+
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ Treg cells - % of Treg
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Follicular B cells - % of CD45+
|
HET
|
2f:1m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Open Field / Percentage center movement time
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.932
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Tail elevation
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / CD4+ T helper cells - % of CD4+
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Count of vg5+ DETC not contacting LC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average volume of vg5+ DETC not contacting LC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F3 tissue volume
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Hindlimb nail - number
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Grip Strength / Forelimb and hindlimb grip strength normalised against body weight
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.575
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Macrophages - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Grip Strength / Body weight
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HET
|
3f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.508
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Myeloid panel singlets cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average no of branches on vg5+ DETC not contacting LC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ CD4+ NKT cells - % of CD45+
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Acoustic Startle and Pre-pulse Inhibition (PPI) / % Pre-pulse inhibition - PPI3
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.164
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total CD4- NKT cells - % of NKT cells
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ CD4+ T helper cells - % of CD4+ T helper cells
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Phosphorus
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.646
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total DC - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Hindpaw - shape
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F1 average branch length of vg5+ DETC not contacting LC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / B2 t1 + t2 cells - cell count
|
HET
|
2f:1m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Hematology / Large Unstained Cell (LUC) count
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.484
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Plasmacytoid DC - % of DC
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F3 average roundness of LC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Head morphology
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Electrocardiogram (ECG) / ST
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.454
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / B1a cells - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting CD8+ T cells - % of CD45+
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F1 average no of branches on vg5+ DETC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Fear Conditioning / % Freezing duration context-1
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.786
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ CD44+ CD62L- alpha beta effector T cell percentage
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ CD44+ CD62L- alpha beta effector T cell percentage
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Follicular B cells - cell count
|
HET
|
2f:1m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Follicular B cells - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting gd T cells - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting CD4+ T helper cells - % of CD45+
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Transitional 1 B cells - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Indirect Calorimetry / Cumulative food intake
|
HET
|
f:176m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ CD4- NKT cells - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Ly6C+ mature NK cells - IMPC panel cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD8+ KLRG1+ alpha beta T cell number
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD8+ KLRG1+ alpha beta T cell number
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Gamma delta T cell number
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Gamma delta T cell number
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total B cells - IMPC panel cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Eye Morphology / Pupil Position
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Open Field / Latency to center entry
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.489
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average volume of LC
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ CD8+ T cells - % of CD8+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Forelimbs - size
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Neutrophil percentage
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Neutrophil percentage
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Early germinal centre B cells - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F3 average roundness of CD45+ vg5- MHC II- cells
|
HET
|
f:1m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Plasmacytoid DC - cell count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
X-ray / Fusion of vertebrae
|
HET
|
5f:5m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Mammary gland
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Mammary gland
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Mammary gland
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Mammary gland
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
X-ray / Tibia
|
HET
|
5f:5m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Eye Morphology / Iris transilumination
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting Treg cells - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector CD4- NKT cells - cell count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total CD4+ T cells - % of ab T cells
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / B2 t3 + f1+ f2 + gc cells - % of lymphocytes
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Count of vg5+ DETC contacting LC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting gd T cells - % of gd T cells
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Head size
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Grip Strength / Forelimb grip strength normalised against body weight
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.212
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Eye Morphology / Left corneal thickness
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.718
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average no of branches on vg5+ DETC contacting LC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Open Field / Center average speed
|
HET
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.195
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting CD4+ T helper cells - % of CD4+ T helper cells
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Forepaw - shape
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
X-ray / Alive
|
HET
|
5f:5m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total B cells - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Germinal centre B cells - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Body Composition (DEXA lean/fat) / Bone Mineral Content (excluding skull)
|
HET
|
8f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.440
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Ly6C+ NKT cells - % of NKT cells
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / CD11b-low cDC - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / B2 marginal zone + precursor cells - cell count
|
HET
|
2f:1m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Hematology / Neutrophil differential count
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0113
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F1 average no of branches on vg5+ DETC not contacting LC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Plasmacytoid DC - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Granulocytes + monocytes - % of CD45+
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector CD8+ T cells - % of CD45+
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Acoustic Startle and Pre-pulse Inhibition (PPI) / % Pre-pulse inhibition - PPI2
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.424
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Hot Plate / Type of response
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector NK cells - % of CD45+
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Eye Morphology / Eye
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Fear Conditioning / Context freezing total
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.180
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting CD4+ NKT cells - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Cytotoxic T cell function / Target cell
|
HET
|
2f:1m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F2 average branch length of vg5+ DETC not contacting LC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total DC - % of myeloid cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Transitional 2 B cells - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector CD4- NKT cells - % of CD45+
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Conventional DC (cDC) - cell count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Naive CD8+ T cells - % of CD45+
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Heart Weight / Tibia length
|
HET
|
5f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.000179
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total B2 cells - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
X-ray / Number of ribs right
|
HET
|
5f:5m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total CD4+ NKT cells - cell count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting CD4+ NKT cells - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Shock Threshold / Jump response
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ CD25+ alpha beta regulatory T cell percentage
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Electrocardiogram (ECG) / PR
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.470
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ gd T cells - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ CD4+ T helper cells - % of CD45+
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total B cells - cell count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F3 average roundness of vg5+ DETC contacting LC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Marginal zone precursor B cells - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Eye Morphology / Right inner nuclear layer
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.367
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Forelimb nail - length
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Immunophenotyping / Others
|
HET
|
3f:3m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ CD4+ T helper cells - cell count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / B2 marginal zone + precursor cells - % of B2 cells
|
HET
|
2f:1m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F3 count of vg5+ DETC contacting LC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Monocyte number
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Monocyte number
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector CD4+ T helper cells - % of CD4+ T helper cells
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Immature NK cells - IMPC panel cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F1 average roundness of LC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Aggression
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / CD103+ CD11b-low cDC - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector Treg cells - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Comment
|
HET
|
f:m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Open Field / Number of center entries
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.437
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector NK cells - % of NK cells
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Startle response
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting Treg cells - % of Treg
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / T cell panel live cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total gd T cells - % of total T cells
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
DSS Histology / Total section 1 score
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
DSS Histology / Total section 1 score
|
HOM
|
4f:4m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
X-ray / Femur
|
HET
|
5f:5m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average no of branches on vg5+ DETC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Eosinophil number
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Eosinophil number
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector CD4+ T helper cells - % of CD4+ T helper cells
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting CD4+ NKT cells - % of CD4+ NKT cells
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Hematology / Basophil cell count
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Body Composition (DEXA lean/fat) / Bone Mineral Density (excluding skull)
|
HET
|
8f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.00643
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Follicular B cells - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Hematology / Red blood cell count
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.176
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting gd T cells - % of CD45+
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Vibrissae - appearance
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Mature NK cells - % of lymphocytes
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Hot Plate / Hot plate latency
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector NK cells - cell count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Granulocytes - % of CD45+
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Fear Conditioning / Freezing duration context
|
HET
|
24f:24m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F3 average no of branches on vg5+ DETC contacting LC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Eosinophils - % of myeloid cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Seminal vesicle
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Seminal vesicle
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Seminal vesicle
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Seminal vesicle
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Cytotoxic T cell function / % CD8+
|
HET
|
2f:1m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector CD8+ T cells - % of CD8+
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / CD4+ T helper cells - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Ratio of vg5+ DETC/LC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Conventional DC (cDC) - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average volume of CD45+ vg5- MHC II- cells
|
HET
|
f:1m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / NK cell number
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / NK cell number
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Coat - color pattern - head
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.332
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / CD11b-high cDC - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / CD5+ gd T cells - % of gd T cells
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ CD4- NKT cells - cell count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ NK cells - cell count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
X-ray / Number of lumbar vertebrae
|
HET
|
5f:5m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Eye Morphology / Left outer nuclear layer
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.656
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Myeloid panel live cell count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector CD4+ NKT cells - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
X-ray / Ulna
|
HET
|
5f:5m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / CD11b-high cDC - cell count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting CD4- NKT cells - % of CD4- NKT cells
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F2 average roundness of vg5+ DETC contacting LC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Uterus
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Uterus
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Uterus
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Uterus
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Buffers and enzymes
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ CD8+ T cells - % of CD45+
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Hindlimb digit - number
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F2 average roundness of LC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / NK cell percentage
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / NK cell percentage
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Unexpected behaviors
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Acoustic Startle and Pre-pulse Inhibition (PPI) / % Pre-pulse inhibition - Global
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.201
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
X-ray / Number of ribs left
|
HET
|
5f:5m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total NK cells - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Transitional 1 B cells - cell count
|
HET
|
2f:1m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / IMPC panel singlets cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total NK cells - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Eye Morphology / Right outer nuclear layer
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0478
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Marginal zone B cells - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / IgD+ mature B cell number
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / IgD+ mature B cell number
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average roundness of LC
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total CD4- NKT cells - % of CD45+
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Forelimbs - position
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting CD4+ T helper cells - cell count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting CD4+ T helper cells - % of CD4+ T helper cells
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Ly6C+ immature NK cells - IMPC panel cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / B2 t1 + t2 cells - % of B2 cells
|
HET
|
2f:1m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / T cell panel CD45+ live cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Acoustic Startle and Pre-pulse Inhibition (PPI) / Response amplitude - PP3_S
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average volume of vg5+ DETC contacting LC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Hematology / Basophil differential count
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Transitional 2 B cells - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Coat - hair texture / appearance - abdomen
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Hot Plate / Body weight
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
DSS Histology / Section 2 Severe Markers
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
DSS Histology / Section 2 Severe Markers
|
HOM
|
4f:4m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Acoustic Startle and Pre-pulse Inhibition (PPI) / Response amplitude - PP2_S
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ CD4+ NKT cells - % of CD4+ NKT cells
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Marginal zone precursor B cells - cell count
|
HET
|
2f:1m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Fear Conditioning / Freezing duration post-us
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Forelimb nail - number
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Monocytes - % of myeloid cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total CD8+ T cells - % of ab T cells
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Cytotoxic T cell function / % CD4+
|
HET
|
2f:1m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Electrocardiogram (ECG) / QRS
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.808
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Langerhans cell (LC) count
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Forelimb digit - number
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F1 count of vg5+ DETC not contacting LC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Ly6C+ mature NK cells - % of lymphocytes
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ CD25+ alpha beta regulatory T cell number
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ CD25+ alpha beta regulatory T cell number
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting NK cells - cell count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Acoustic Startle and Pre-pulse Inhibition (PPI) / % Pre-pulse inhibition - PPI4
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.248
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Granulocytes - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Body Composition (DEXA lean/fat) / Lean mass
|
HET
|
8f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.674
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector CD4- NKT cells - % of CD4- NKT cells
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Ly6C+ CD5+ T cells - % of lymphocytes
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
X-ray / Number of pelvic vertebrae
|
HET
|
5f:5m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Monocytes - % of CD45+
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F2 average no of branches on vg5+ DETC contacting LC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Ovary
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Ovary
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Ovary
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Ovary
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Hematology / White blood cell count
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0335
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Marginal zone B cells - % of B2 cells
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Total B cells - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Forelimb digit - size
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Eye Morphology / Ophthalmoscope Observation
|
HET
|
6f:7m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average roundness of vg5+ DETC contacting LC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Skin texture - whole body
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / BM panel lymphocyte gate cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Creatinine
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.661
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / T cell panel lymphocyte gate cell count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ CD4+ T helper cells - % of CD4+ T helper cells
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ CD4- NKT cells - % of CD4- NKT cells
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Immunophenotyping / Eosinophils
|
HET
|
3f:3m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Myeloid panel live cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F1 average branch length of LC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / B1a cells - % of CD45+
|
HET
|
2f:1m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
X-ray / Radius
|
HET
|
5f:5m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Memory B cells - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Hematology / Eosinophil differential count
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.377
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F1 average no of branches on vg5+ DETC contacting LC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F3 average branch length of vg5+ DETC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
X-ray / Brachydactyly
|
HET
|
5f:5m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total gd T cells - % of CD45+
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Late germinal centre B cells - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
X-ray / Scapulae
|
HET
|
5f:5m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total CD4- NKT cells - % of NKT cells
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Shock Threshold / Shock Intensity Vocalization
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Alpha beta T cell number
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Alpha beta T cell number
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Naive CD8+ T cells - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Vg5+ dendritic epidermal T cell (DETC) count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F3 vg5+ DETC count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / T cell panel CD45+ live cell count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Immature NK cells - % of lymphocytes
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Eye Morphology / Corneal mineralization
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
0.000131
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ CD4+ NKT cells - cell count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Heart Weight / Body weight
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Spleen
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Spleen
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Spleen
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Spleen
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Fear Conditioning / Freezing duration habituation
|
HET
|
16f:16m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Granulocytes - % of myeloid cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F3 ratio of vg5+ DETC/LC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Contact righting
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Hematology / Hematocrit
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.381
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Immunophenotyping / DN NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F2 average volume of vg5+ DETC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Granulocytes + monocytes - % of myeloid cells
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Immature B cells (Hardy fraction E) - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Ly6Clow monocyte number
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Ly6Clow monocyte number
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector CD8+ T cells - cell count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Coat - color - abdomen
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
DSS Histology / Section 2 Area
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
DSS Histology / Section 2 Area
|
HOM
|
4f:4m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Late germinal centre B cells - cell count
|
HET
|
2f:1m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Eye Morphology / Pupil Dilation
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Fear Conditioning / % Freezing duration habituation-2
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.254
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ CD4+ NKT cells - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Eye Morphology / Left inner nuclear layer
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.854
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Pre-pro B cells (Hardy fraction A) - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Tremor
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
0.204
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ Treg cells - % of Treg
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Marginal zone precursor B cells - % of B2 cells
|
HET
|
2f:1m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total Treg cells - % of CD45+
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Brain
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Brain
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Brain
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Brain
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Indirect Calorimetry / Total water intake
|
HET
|
f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.305
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ NK cells - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F2 count of vg5+ DETC not contacting LC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Indirect Calorimetry / Carbon dioxide production
|
HET
|
f:128m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Intraperitoneal glucose tolerance test (IPGTT) / Body Weight
|
HET
|
3f:8m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Open Field / Center distance travelled
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.607
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Auditory Brain Stem Response / 18kHz-evoked ABR Threshold
|
HET
|
8f:8m
|
Reference Range Plus Test framework; quantile = 0.95 (Tails probability = 0.025)
|
0.0392
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / CD103+ CD11b-low cDC - % of CD11b-low cDC
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Fear Conditioning / Freezing duration pre-cue
|
HET
|
16f:16m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
X-ray / Clavicle
|
HET
|
5f:5m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Body Weight / Body weight curve
|
HET
|
58f:72m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total Treg cells - % of CD4+
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / B cell panel live cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F3 count of vg5+ DETC not contacting LC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F3 average branch length of vg5+ DETC not contacting LC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Immunophenotyping / Monocytes
|
HET
|
3f:3m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / B cell panel CD45+ live cell count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Mature B cells (Hardy fraction F) - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Hindlimb digit - size
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector CD4- NKT cells - % of CD4- NKT cells
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting CD4+ T helper cells - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average roundness of vg5+ DETC not contacting LC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Fear Conditioning / % Freezing duration habituation-1
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.621
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
X-ray / Digit integrity
|
HET
|
5f:5m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total CD4+ NKT cells - % of NKT cells
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Marginal zone precursor B cells - % of B2 cells
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Eye Morphology / Slit Lamp observation
|
HET
|
f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Skin texture - snout
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Total protein
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.247
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HET
|
8f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0783
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / B cell panel lymphocyte gate cell count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Immunophenotyping / Follicular B Cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total B2 cells - % of CD45+
|
HET
|
2f:1m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F3 average volume of vg5+ DETC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Shock Threshold / Shock Intensity Jump
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ CD8+ T cells - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Ly6Chigh monocyte number
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Ly6Chigh monocyte number
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Pre-B cells (Hardy fraction D) - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ gd T cells - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F2 vg5+ DETC count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
DSS Histology / Section 1 Epithelium
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
DSS Histology / Section 1 Epithelium
|
HOM
|
4f:4m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / CD45+ vg5- MHC II- cell count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / BM panel CD45+ cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Hematology / Eosinophil cell count
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.946
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Vocalization
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F1 average branch length of vg5+ DETC contacting LC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / CD5+ gd T cells - % of CD45+
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Hematology / Hemoglobin
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.237
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Ly6C+ immature NK cells - % of lymphocytes
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Indirect Calorimetry / Cumulative water intake
|
HET
|
f:154m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Plasma cells - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Indirect Calorimetry / Heat production (metabolic rate)
|
HET
|
f:128m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Total T cell number
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Total T cell number
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Eye Morphology / Vitreous
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
0.0928
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector gd cells - % of CD45+
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total ab T cells - % of CD45+
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F2 ratio of vg5+ DETC/LC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Coat - color pattern - back
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Eye Morphology / Optic Disc
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
0.000225
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Pro-B cells (Hardy fractions B and C) - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting CD8+ T cells - cell count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total NK cells - cell count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Heart Weight / Heart weight
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.632
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total NK cells - IMPC panel cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F2 average roundness of CD45+ vg5- MHC II- cells
|
HET
|
f:1m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting gd T cells - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / B2 marginal zone + precursor cells - % of lymphocytes
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Immunophenotyping / Total number of acquired events in Panel B
|
HET
|
3f:3m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
DSS Histology / Section 2 Lamina Propria
|
HOM
|
4f:4m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
DSS Histology / Section 2 Lamina Propria
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Eye Morphology / Pupil Shape
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HET
|
15f:40m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Open Field / Periphery average speed
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.183
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Fear Conditioning / Freezing duration cue
|
HET
|
16f:16m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector NK cells - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total CD8+ T cells - % of ab T cells
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Plasma cells - cell count
|
HET
|
2f:1m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector CD4+ NKT cells - % of CD4+ NKT cells
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Transfer arousal
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Pancreas
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Pancreas
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Pancreas
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Pancreas
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector CD4+ T helper cells - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Immunophenotyping / Neutrophils
|
HET
|
3f:3m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Germinal centre B cells - cell count
|
HET
|
2f:1m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Hematology / Monocyte differential count
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0910
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
DSS Histology / Section 1 Lamina Propria
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
DSS Histology / Section 1 Lamina Propria
|
HOM
|
4f:4m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Spinal cord
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Spinal cord
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Spinal cord
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Spinal cord
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F1 LC count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Body Composition (DEXA lean/fat) / Lean/Body weight
|
HET
|
8f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.225
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F2 average no of branches on vg5+ DETC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD8+ alpha beta T cell number
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD8+ alpha beta T cell number
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ CD4+ T helper cells - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting NK cells - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Immunophenotyping / Total number of acquired events in Panel A
|
HET
|
3f:3m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Germinal centre B cells - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Auditory Brain Stem Response / 24kHz-evoked ABR Threshold
|
HET
|
8f:8m
|
Reference Range Plus Test framework; quantile = 0.95 (Tails probability = 0.025)
|
0.0280
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Myeloid panel CD45+ live cell count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Immature B cells (Hardy fraction E) - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F1 vg5+ DETC count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Albumin
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.877
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Adrenal gland
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Adrenal gland
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Adrenal gland
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Adrenal gland
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Late germinal centre B cells - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total NKT cells - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Myeloid panel lymphocyte gate cell count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total ab T cells - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector CD4+ NKT cells - cell count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average roundness of vg5+ DETC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Forelimb digit - shape
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Hematology / Mean cell volume
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0118
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Coat - color - back
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Pro-B cells (Hardy fraction C) - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Pro-B cells (Hardy fraction B) - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Eye Morphology / Left anterior chamber depth
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.791
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Open Field / Center permanence time
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.844
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector CD8+ T cells - % of CD8+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Monocytes - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total myeloid cells - % of CD45+
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total B2 cells - % of B cells
|
HET
|
2f:1m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F2 average roundness of vg5+ DETC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Upper lip morphology
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Locomotor activity
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.394
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F2 average branch length of vg5+ DETC contacting LC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector NK cells - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ gd T cells - % of gd T cells
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Indirect Calorimetry / Ambulatory activity (no. of beam cuts)
|
HET
|
f:176m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Macrophages - % of CD45+
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Fear Conditioning / % Freezing duration cue-1
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total CD4+ T cells - % of CD45+
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Eye Morphology / Retinal Blood Vessels
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
0.000390
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
DSS Histology / Section 2 Epithelium
|
HOM
|
4f:4m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
DSS Histology / Section 2 Epithelium
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Naive CD8+ T cells - cell count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total gd T cells - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / B1a cells - % of B cells
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
X-ray / Mandibles
|
HET
|
5f:5m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Skin color - back paws
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector Treg cells - % of Treg
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Anti-nuclear antibody assay / ANA score
|
HET
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Anti-nuclear antibody assay / ANA score
|
HET
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting NK cells - % of CD45+
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Immunophenotyping / Transitional B Cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ NK cells - % of CD45+
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / B2 t3 + f1 + f2 + gc cells - % of B2 cells
|
HET
|
2f:1m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total NKT cells - IMPC panel cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Pro-B cells (Hardy fraction B) - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Plasma cells - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Eye Morphology / Corneal Sclerization
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Anti-nuclear antibody assay / ANA classification
|
HET
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Anti-nuclear antibody assay / ANA classification
|
HET
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total T cells - cell count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / IMPC panel live cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Early germinal centre B cells - cell count
|
HET
|
2f:1m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Hematology / Monocyte cell count
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.992
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
DSS Histology / Section 1 Area
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
DSS Histology / Section 1 Area
|
HOM
|
4f:4m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
X-ray / Teeth
|
HET
|
5f:5m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F3 average no of branches on vg5+ DETC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ alpha beta T cell number
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ alpha beta T cell number
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / CD4+ T helper cells - % of CD45+
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total NKT cells - % of CD45+
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Immunophenotyping / NK Cells (panel B)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Early germinal centre B cells - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F2 LC count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / DETC coverage
|
HET
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Coat - color - head
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Hematology / Mean corpuscular hemoglobin
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.934
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total CD4+ T cells - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total Treg cells - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Hindlimb digit - shape
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ NK cells - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Pre-B cells (Hardy fraction D) - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Total bilirubin
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.199
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Indirect Calorimetry / Total activity (no. of fine movement + no. of beam cuts)
|
HET
|
f:176m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average roundness of CD45+ vg5- MHC II- cells
|
HET
|
f:1m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Shock Threshold / Shock Intensity Flinch
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / 3i T cell panel
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Body Composition (DEXA lean/fat) / BMC/Body weight
|
HET
|
8f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.374
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Lower lip morphology
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting NK cells - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F2 tissue volume
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting CD4+ NKT cells - cell count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Neutrophil number
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Neutrophil number
|
HET
|
7f:5m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Open Field / Center resting time
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.215
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F3 average branch length of vg5+ DETC contacting LC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Eye Morphology / Retinal Blood Vessels Structure
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Eye Morphology / Left total retinal thickness
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.207
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting CD8+ T cells - % of CD8+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Macrophages - % of myeloid cells
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Eosinophils - cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Marginal zone B cells - % of B2 cells
|
HET
|
2f:1m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Gait
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Kidney
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Kidney
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Kidney
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / T cell panel lymphocyte gate cell count
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
X-ray / Tibia length
|
HET
|
5f:5m
|
Linear Mixed Model framework, LME, including Weight
|
2.33×10-05
|
Successful |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
DSS Histology / Section 1 Severe Markers
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
DSS Histology / Section 1 Severe Markers
|
HOM
|
4f:4m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / CD5+ gd T cells - % of CD45+
|
HET
|
3f:2m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Acoustic Startle and Pre-pulse Inhibition (PPI) / Response amplitude - PP4_S
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ CD8+ T cells - cell count
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total B2 cells - % of B cells
|
HET
|
3f:2m
|
|
|
NotProcessed |
Lmnatm1a(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F3 average roundness of vg5+ DETC
|
HET
|
2f:2m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Combined SHIRPA and Dysmorphology / Skin color - tail
|
HET
|
8f:8m
|
|
|
NotProcessed |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Eye with optic nerve
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Eye with optic nerve
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Eye with optic nerve
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Lmnatm1b(EUCOMM)Wtsi
|
ICS
|
Gross Pathology and Tissue Collection / Eye with optic nerve
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |